new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)





Similar
Filing Names

Universite Paris Descartes
Universite Paris Descartes Paris V
Universite Paris Descartes paris V
Universite Paris Descartes_20131212
  

Universite Paris Descartes patents

Recent patent applications related to Universite Paris Descartes. Universite Paris Descartes is listed as an Agent/Assignee. Note: Universite Paris Descartes may have other listings under different names/spellings. We're not affiliated with Universite Paris Descartes, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "U" | Universite Paris Descartes-related inventors




Date Universite Paris Descartes patents (updated weekly) - BOOKMARK this page
05/25/17 new patent  Use of compounds inhibiting apelin / apj / gp130 signaling for treating cancer
05/11/17Methods for predicting acute rejection in heart recipients
05/04/17Composition comprising a combination of dna methylation inhibitor and a vitamin d receptor agonist for the treatment of drug resistant cancer or for the prevention of tumor relapse
02/23/17Methods and pharmaceutical compositions for treating vaso-occlusive crisis
02/23/17Methods and pharmaceutical compositions for the treatment of diseases mediated by the nrp-1/obr complex signaling pathway
02/23/17Rapid detection of the "high virulent" st-17 clone of group b streptococcus
02/16/17Compositions having means for targeting at least one antigen to dendritic cells
02/16/17Methods for the treatment of leber congenital amaurosis
02/16/17Methods for the diagnostic of an autoimmune disease
01/26/17Methods and pharmaceutical compositions for the treatment of beta-thalassemias
01/19/17Optical system comprising a spatial light modulator
11/17/16Water soluble 4-azapodophyllotoxin analogs
11/03/16Combination of bezafibrate and of resveratrol or resveratrol derivatives for the treatment and prevention of diseases involving a mitochondrial energy dysfunction
11/03/16Tet2 as a diagnostic and pronostic marker in hematopoietic neoplasms
09/01/16Methods and pharmaceutical compositions for modulating autophagy in a subject in need thereof
09/01/16New methods to produce active tert
08/18/16Simultaneous monitoring of fibrinogen and haematocrit in whole blood
07/28/16Method for in vitro quantifying allo-antibodies, auto-antibodies and/or therapeutic antibodies
06/30/16Vaccines for preventing meningococcal infections
06/23/16Il-15 and il-15raplha sushi domain based modulokines
06/09/16Method for treating cancer
06/02/16Use of gingival fibroblasts in the treatment of alopecia
05/26/16Method for the prognosis of survival time of a patient suffering from a solid cancer
05/26/16Methods for performing antisense oligonucleotide-mediated exon skipping in the retina of a subject in need thereof
05/19/16Pharmaceutical compositions for preventing glucocorticoid-induced corneal or skin thinning
05/12/16Use of urinary hiv nucleic acids to diagnose and monitor hiv-associated nephropathy (hivan)
04/21/16Cgrp receptor agonist for hiv treatment or prevention
03/24/16Methods and compositions for stimulating reepithelialisation during wound healing
03/10/16New drug for the treatment and/or prevention of depressive disorders
02/25/16Antagonist of the fibroblast growth factor receptor 3 (fgfr3) for use in the treatment or the prevention of skeletal disorders linked with abnormal activation of fgfr3
02/18/16Method for monitoring cancer and/or inflammatory reaction based on relb phosphorylation
02/11/16Method and pharmaceutical composition for use in the treatment of cancer
10/22/15Method for classification of liver samples and diagnosis of focal nodule dysplasia, hepatocellular adenoma, and hepatocellular carcinoma
10/15/15Glycoconjugates and their use as potential vaccines against infection by shigella flexneri
09/24/15Method for renal transplantation
09/24/15In vitro the prognosis of progression of a cancer and of the outcome in a patient and means for performing said method
09/17/15Methods for preventing antiphospholipid syndrome (aps)
08/20/15Method for prognosis of global survival and survival without relapse in hepatocellular carcinoma
08/13/15Methods for predicting the outcome of a cancer in a patient by analysing gene expression
08/06/15Methods and compositions for the treatment of fluid accumulation in and/or under the retina
08/06/15Methods and kits for screening patients with a cancer
07/23/15Methods for predicting the survival time and treatment responsiveness of a patient suffering from a solid cancer with a signature of at least 7 genes
07/16/15Use of transferrin receptor antagonist for the treatment of thalassemia
06/18/15Methods and kits for determining whether a patient with cirrhosis is at risk of having clinically significant portal hypertension
06/04/15Method for quantifying immune cells in tumoral tissues and its applications
05/14/15Anellovirus genome quantification as a biomarker of immune suppression
05/07/15Method and pharmaceutical composition for use in the treatment of cancer
04/23/15Cd147 as receptor for pilus-mediated adhesion of meningococci to vascular endothelia
04/23/15Method for in vitro differentiation of blood circulating cells into neuronal-like cells and applications thereof
04/23/15Methods for the treatment of leber congenital amaurosis
04/16/15Methods and kits for predicting the risk of having a cardiovascular event in a subject
04/16/15Method for the selection of serum biomarkers of epigenetic alterations, particularly of global hypomethylation and their uses
04/16/15Methods and pharmaceutical compositions for prevention or treatment of ischemia related organ damage
04/16/15Topical emulsions based on mixtures of local eutectic anaesthetics and fatty acids as analgesics, antalgics, or as sexual retardants
04/16/15Method for diagnosing a skeletal ciliopathy
03/19/15Microscope for high spatial resolution imaging a structure of interest in a sample
03/12/15Methods and pharmaceutical compositions for the treatment of hypertension
03/05/15Materials coated with calixarenes
02/26/15Methods for the treatment of nonalcoholic steatohepatitis
02/19/15Glycoconjugates and use thereof as vaccine against shigella flexneri serotype 3a and x
02/19/15Method and pharmaceutical composition for use in the treatment or the prevention of aneurysm
02/19/15Method for measuring calcineurin activity
01/22/15Number of il4 and/or il13 secreting t-cells as a biomarker for allergic diseases
01/15/15Combination product for treating excess weight and/or for improving the figure
01/01/15Vaccine compositions for hiv prevention and treatment
Patent Packs
01/01/15Method for the prognosis of survival time of a patient suffering from a solid cancer
12/18/14Method for predicting responsiveness to a treatment with an egfr inhibitor
06/26/14Method of neonatal serological diagnosis
04/24/14Erk inhibitors for use in treating spinal muscular atrophy
04/17/14Hypophosphorous acid derivatives having antihyperalgic activity and biological applications thereof
01/23/14Methods and pharmaceutical compositions for the treatment of ocular inflammatory diseases
01/16/14Methods for predicting the outcome of a cancer in a patient by analysing gene expression
01/16/14Preventive effect of citrulline on the spontaneous development of tumors
01/02/14Methods and kits for predicting the risk of having a cardiovascular event in a subject
12/12/13Method for predicting the outcome of colon cancer by analysing mirna expression
10/31/13Vaccines for preventing meningococcal infections
08/08/13Specific detection of human chorionic gonadotropin beta subunit type ii produced by trophoblastic and neoplastic cells
01/10/13Methods for intracellular delivery of nucleic acids
08/23/12Method and device for cancelling acoustic echo by audio watermarking
07/19/12Pyrazolo[1,5-a]-1,3,5-triazine derivatives, preparation thereof, and therapeutic use thereof
Patent Packs
04/26/12Method for treating cancer
04/19/12Vectors including an anionic macromolecule and a cationic lipid for delivering small nucleic acids
01/19/12Method for producing platelets
11/04/10Perharidines as cdk inhibitors
09/23/10Glycoconjugates and use thereof as vaccine against shigella flexneri serotype 3a and x
06/03/10Method of producing a multichimeric mouse and applications to study the immunopathogenesis of human tissue-specific pathologies
12/10/09Compositions and methods for treating diabetes and neuropsychological dysfunction
12/12/13Method for predicting the outcome of colon cancer by analysing mirna expression
10/22/15Methods for the treatment and diagnosis of atherosclerosis
03/26/15Cryopreservation of cells, tissues and organs
12/22/16Methods and compositions for the treatment of beta-thalassemia
12/22/16Methods for diagnosing and treating myhre syndrome
12/24/15Methods for predicting the survival time of a patient suffering from a solid cancer
05/21/15Methods and compositions for the treatment of beta-thalassemia
10/16/14Methods for diagnosing and treating myhre syndrome







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Universite Paris Descartes in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Universite Paris Descartes with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';